⌘K
Loading ticker…
As of 2026-08-24, BioCardia, Inc. Common Stock (BCDA) has a 3-month relative strength percentile of 69 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 46. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 7.8%, relative volume 1.10×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
BCDA is held by 2 ETFs as of Mar 2026. Top owner: VXF at 0.00% weight, $84K notional.
Held by 2 ETFs · $151K across latest filings · largest weight 0.00% (VXF).
Top 2 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VXFVanguard Extended Market ETF | 0.00% | $84K | — |
| VTIVanguard Total Stock Market ETF | 0.00% | $67K | new |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | BCDA Jan avg: 0.37% median: 5.85% win: 50% σ: 23.46% n: 4 2022-04-12 → 2026-07-31 | BCDA Feb avg: -1.44% median: -4.25% win: 50% σ: 18.24% n: 4 2022-04-12 → 2026-07-31 | BCDA Mar avg: -4.30% median: -8.78% win: 25% σ: 22.10% n: 4 2022-04-12 → 2026-07-31 | BCDA Apr avg: -1.96% median: -4.89% win: 40% σ: 18.93% n: 5 2022-04-12 → 2026-07-31 | BCDA May avg: -15.01% median: -18.42% win: 20% σ: 14.88% n: 5 2022-04-12 → 2026-07-31 | BCDA Jun avg: 5.01% median: -9.72% win: 40% σ: 35.81% n: 5 2022-04-12 → 2026-07-31 | BCDA Jul avg: -16.77% median: 0.00% win: 40% σ: 29.95% n: 5 2022-04-12 → 2026-07-31 | BCDA Aug avg: 1.67% median: -3.14% win: 50% σ: 25.98% n: 4 2022-04-12 → 2026-07-31 (current) | BCDA Sep avg: -19.96% median: -18.63% win: 25% σ: 23.38% n: 4 2022-04-12 → 2026-07-31 | BCDA Oct avg: -7.42% median: -6.44% win: 50% σ: 14.98% n: 4 2022-04-12 → 2026-07-31 | BCDA Nov avg: 15.79% median: 0.71% win: 50% σ: 34.23% n: 4 2022-04-12 → 2026-07-31 | BCDA Dec avg: 0.43% median: 1.27% win: 50% σ: 11.90% n: 4 2022-04-12 → 2026-07-31 |